ABP
ABP
NASDAQ · Biotechnology

Abpro Holdings Inc

$1.50
+0.00 (+0.00%)
As of Feb 8, 2:33 PM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 38%
Sell 5 63%
Price Target
Analyst Price Target +2,295.3% upside
Low Target $28.98
Average Target $35.93
High Target $50.96
Current Price $1.50
Current
$1.50
Target
$35.93
$28.98 $35.93 avg $50.96
Scenario Analysis
Bear Case
$28.98
1,832.0%
Low target
Base Case
$35.93
+2,295.3%
Avg target
Bull Case
$50.96
+3,297.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$43.45
-96.5% from high
52-Week Low
$27.61
+-94.6% from low
Target vs 52W High
$35.93
-17.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%